Against the backdrop of continuous iteration and upgrading of medical technologies, minimally invasive diagnosis and treatment has become an important direction for the development of modern medicine, boasting prominent advantages including minimal trauma, rapid recovery and few complications. As the key backbone of minimally invasive therapy, endoscopic minimally invasive diagnosis and treatment instruments are playing an increasingly important role in clinical practice. Global sales of endoscopic minimally invasive diagnosis and treatment instruments hit USD 4.524 billion in 2024. This figure not only highlights their vital standing in the healthcare sector, but also reflects the huge development potential of this market amid growing medical demands and technological advances. Market sales are expected to rise to USD 7.284 billion by 2031, with a Compound Annual Growth Rate (CAGR) of 7.1% over 2025–2031. This stable and impressive growth trend indicates that the market for endoscopic minimally invasive instruments will embrace a golden period of vigorous development in the coming years.

I. Full-Scale Analysis of Current Market Conditions

1.1 Rich and Diversified Product Categories

Endoscopic minimally invasive diagnosis and treatment instruments cover a wide array of types to satisfy diverse clinical demands. Functionally, they are roughly split into diagnostic instruments and therapeutic instruments.

Within diagnostic equipment, endoscopes serve as core products, including gastroscopes, colonoscopes, bronchoscopes, laparoscopes and others. Taking gastroscopes as an example, global gastroscope sales reached approximately USD 1 billion in 2024, accounting for around 30% of the total endoscope market share. High-definition gastroscopes feature exceptional image resolution that clearly displays subtle structures of gastric mucosa, enabling clinicians to accurately identify early lesions, and are widely favored in the high-end market. Conventional gastroscopes, by contrast, are extensively used in primary medical institutions due to cost advantages. As an essential device for Endoscopic Retrograde Cholangiopancreatography (ERCP), duodenoscopes generated about USD 300 million in sales in 2024. By injecting contrast agents into biliary and pancreatic ducts, duodenoscopes help physicians observe duct structures and carry great significance for the diagnosis of biliary and pancreatic disorders.

Therapeutic instruments also feature abundant varieties. Snare devices are used to resect lesion tissues such as gastrointestinal polyps and tumors, with global sales of roughly USD 600 million in 2024. Snares of various specifications fit lesions of different sizes and shapes, and the material’s flexibility and cutting performance directly determine surgical outcomes. Biopsy forceps extract lesion tissue for pathological examination and recorded sales of around USD 500 million; precise grasping performance and excellent tissue biocompatibility form their core competitiveness. Endoscopic electrosurgical instruments including electrosurgical knives and argon plasma coagulators rely on electric energy to perform tissue cutting, hemostasis and other operations, posting a market size of about USD 800 million in 2024. Widely applied in gastrointestinal and respiratory surgeries, their advanced energy control technology improves surgical safety and accuracy. In addition, a full range of instruments such as injection needles, stone retrieval baskets and dilation balloons each play an irreplaceable role in specific diagnosis and treatment scenarios.

1.2 Extensively Expanding Application Fields

Endoscopic minimally invasive diagnosis and treatment instruments are widely applied across multiple systems such as the digestive, respiratory and urinary systems.

In the digestive system, they are mainly adopted for the diagnosis and treatment of gastrointestinal, biliary and pancreatic diseases. Over 50 million patients worldwide received endoscopic minimally invasive treatment for gastrointestinal diseases in 2024, including gastrointestinal polypectomy and endoscopic therapy for early gastric cancer, which drove rising market demand for relevant instruments. For biliary and pancreatic diseases, ERCP procedures supported by endoscopic instruments can effectively treat cholelithiasis, cholangitis and other ailments. Roughly 2 million ERCP surgeries were performed globally in 2024, pushing up sales of duodenoscopes, stone retrieval baskets, stents and other equipment.

In the respiratory field, bronchoscopes are commonly used for the diagnosis and treatment of pulmonary diseases, such as early lung cancer screening, pulmonary foreign body removal and airway stricture dilation. Around 15 million patients worldwide received bronchoscopic diagnosis and treatment for respiratory disorders in 2024, fueling market growth for bronchoscopes and matching accessories including biopsy forceps and cytology brushes.

In the urinary system, cystoscopes, ureteroscopes and other devices diagnose and treat urinary calculi, tumors, inflammations and other conditions. Approximately 8 million relevant surgeries were completed worldwide in 2024, boosting the application and market expansion of endoscopic minimally invasive instruments in this sector.

1.3 Diversified and Integrated Sales Channels

At present, sales channels for endoscopic minimally invasive instruments show a trend of diversified integration. Medical device distributors dominate the market with extensive customer resources and mature logistics networks; around 60% of all products were sold to medical institutions at all levels via distributors in 2024. Large distributors usually cooperate with multiple well-known device manufacturers and can provide one-stop procurement services for medical facilities to meet the diverse purchasing needs of hospitals of all sizes.

Direct sales by manufacturers constitute another important channel, accounting for roughly 30% of total sales. By directly cooperating with large tertiary hospitals and chain medical groups, manufacturers can better understand customer needs and deliver customized technical support and after-sales services, such as tailor-made endoscopy equipment configuration plans and instrument operation training for hospitals.

Driven by internet technology, the share of e-commerce platform sales has gradually climbed, reaching about 10% in 2024 with robust growth momentum. Online medical device marketplaces offer convenient procurement channels for small medical institutions and clinics, featuring transparent pricing and streamlined purchasing workflows. Many manufacturers also carry out product promotion and technical lectures via online platforms to boost brand awareness and product influence. Furthermore, participating in medical device exhibitions and hosting academic conferences are key approaches for enterprises to market products and expand sales channels. Through direct communication with medical institutions and industry experts, companies can showcase product strengths and collect market feedback.

Thank you for following the official platform of Vanworld! We are committed to providing you with professional, reliable and cutting-edge medical and health information.

Kind Reminder: All content released on this platform is for popular science of health knowledge only, intended to share more health-related information, and shall not replace professional medical diagnosis. Please be sure to consult a qualified doctor and strictly follow medical advice for specific diagnosis and treatment plans.

Disclaimer: The content of this article is sourced from the internet for the purpose of sharing additional information and industry insights. All viewpoints expressed herein solely belong to the original author and do not represent the stance of this platform.Should any copyright or content disputes arise, please contact us immediately. We will verify the relevant information and revise or remove the content promptly. Thank you for your understanding and support!